TY - JOUR
T1 - Mindfulness meditation for substance use disorders
T2 - A systematic review
AU - Zgierska, Aleksandra
AU - Rabago, David
AU - Chawla, Neharika
AU - Kushner, Kenneth
AU - Koehler, Robert
AU - Marlatt, Alan
N1 - Funding Information:
Aleksandra Zgierska, David Rabago, and Kenneth Kushner are affiliated with the Department of Family Medicine, University of Wisconsin, School of Medicine and Public Health, Madison, Wisconsin, USA. Neharika Chawla and Alan Marlatt are affiliated with the Addictive Behaviors Research Center, Department of Psychology, University of Washington, Seattle, Washington, USA. Robert Koehler is affiliated with Meriter Hospital Library, Meriter Hospital, Madison, Wisconsin, USA. Address correspondence to: Aleksandra Zgierska, MD, PhD, Department of Family Medicine, 1100 Delaplaine Court, Madison, WI 53715 USA (E-mail: Aleksandra.Zgierska@fammed.wisc.edu). This study was supported by grants from the National Institute on Alcohol Abuse and Alcoholism (5T32 AA014845—A.Z., and K23 AA017508—A.Z.).
PY - 2009/10
Y1 - 2009/10
N2 - Relapse is common in substance use disorders (SUDs), even among treated individuals. The goal of this article was to systematically review the existing evidence on mindfulness meditation-based interventions (MM) for SUDs. The comprehensive search for and review of literature found over 2000 abstracts and resulted in 25 eligible manuscripts (22 published, 3 unpublished: 8 randomized controlled trials, 7 controlled nonrandomized, 6 noncontrolled prospective, and 2 qualitative studies, and 1 case report). When appropriate, methodological quality, absolute risk reduction, number needed to treat, and effect size were assessed. Overall, although preliminary evidence suggests MM efficacy and safety, conclusive data for MM as a treatment of SUDs are lacking. Significant methodological limitations exist in most studies. Further, it is unclear which persons with SUDs might benefit most from MM. Future trials must be of sufficient sample size to answer a specific clinical question and should target both assessment of effect size and mechanisms of action.
AB - Relapse is common in substance use disorders (SUDs), even among treated individuals. The goal of this article was to systematically review the existing evidence on mindfulness meditation-based interventions (MM) for SUDs. The comprehensive search for and review of literature found over 2000 abstracts and resulted in 25 eligible manuscripts (22 published, 3 unpublished: 8 randomized controlled trials, 7 controlled nonrandomized, 6 noncontrolled prospective, and 2 qualitative studies, and 1 case report). When appropriate, methodological quality, absolute risk reduction, number needed to treat, and effect size were assessed. Overall, although preliminary evidence suggests MM efficacy and safety, conclusive data for MM as a treatment of SUDs are lacking. Significant methodological limitations exist in most studies. Further, it is unclear which persons with SUDs might benefit most from MM. Future trials must be of sufficient sample size to answer a specific clinical question and should target both assessment of effect size and mechanisms of action.
UR - http://www.scopus.com/inward/record.url?scp=71049116753&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=71049116753&partnerID=8YFLogxK
U2 - 10.1080/08897070903250019
DO - 10.1080/08897070903250019
M3 - Article
C2 - 19904664
AN - SCOPUS:71049116753
VL - 30
SP - 266
EP - 294
JO - Substance Abuse
JF - Substance Abuse
SN - 0889-7077
IS - 4
ER -
